HarNeedi - Healthcare & Pharma Job Portal

VERTICAL FARMING, THE FUTURE OF FARMING: Have you ever thought, what could happen if there is no or few land left for farming? Answer would definitely be, deficiency of food. Yes, due to this deficiency of food substances, people may compete with each other and as per Charles Darwin theory “Only survival of the fittest” will be observed, leading a big question mark on the peaceful existence of Human race. It is been estimated that by the end of 2050, near to 80% of the earth’s population will reside in urban centers. It is also been estimated that, by employing the conservative estimates to present demographic trends, the human population will be increased by about 3 billion people during the interim. As per the analysis conducted by FAO and NASA, 109 hectares of fresh land is required to cultivate crops in order to balance the food requirement, through traditional farming practices as they are practiced today. At present, around 80% of the land present in earth’s surface is ...

Very frequently we will be seeing that, someone in a biopharma company will say “it’s time to think about GMP training”. This statement will generally be received with little exuberance from those who get to know however even so a plan will be in place to conduct GMP training over the next 4 or 5 months or so. On the training day the majority of the resources will present with evenly low levels of enthusiasm as the GMP session begins. “Well let’s start” the GMP trainer will say, as the participants think “well let’s get this over and done with” as they pay close attention to the focus area of this time training – which is generally what they did so poorly wrongly last time! In point of fact, the same could be conveyed for most training departments. They covetously guard their turf and present average, cursory training. Now this might not be incisively what happens in your company however some components of the above are the correct. This does implore some really import...

Drug Interactions & Its Introduction: “The person who takes medicine must recover twice, once from the disease and once from the medicine”. – William Osler, M.D. Drug Interaction:  A mechanism by which a drug interact with the action(s) of another drug or the modification of the action of a drug by the concurrent or prior administration of another drug is known as drug interaction. When we talk about drug interaction, generally interaction between the drugs comes in mind (Drug-Drug interaction). It has been observed that interaction may also exist between drugs & foods (Drug-food interaction), as well as drugs & herbs (Drug-herbs interactions). Mostly drug interaction should be avoided as it may produce unexpected or poor outcomes. Sometimes it is used intentionally, as it may help in retarding the excretion of useful drug molecule, who presence in the body can heal the disease during the course of the therapy. Example of Beneficial Drug Interaction: Carbidopa wit...

Marketing Excellence: ​Currently, product success in biopharma segment decided by company’s ability to prove satisfactory value in an accessible population. To be commercially workable, product must bring possible grounds to support the value they provide, presenting a positive balance within the clinical and non clinical does good, the financial and therapy burden costs. The information must give an apparent transcendency for a clinical requirement in contact with current choices and present this transcendency is worth the monetary value. Seriously, both of these areas are compelling recognition by both treating medical practitioners and those financing the new approach. Making out perfectly necessitates biopharma to be more accurate when getting the brands in market. It is now important to work up commercial and the right enter in to clinical development as soon as possible and constantly through the product life cycle. This can be achievable when clinical and medical exper...

Before a pharmaceutical product can go to a new market or developing market, filling must be composed and filed with all relevant regulatory agencies to seek a review and finally regulatory approval. Each jurisdiction has its own procedures or procedures to review drug submissions filed to their regulatory authority. These procedures can change considerably with respect to How the drug submission will be managed, The constitution of the review team, Review timelines etc; In spite of the divergences, the procedures to turn over regulatory approval generally follow these stages: Pre filling or Pre-Submission meeting: ​ Even though left to personal choice, a pre filling meeting is often helpful so that any regulatory submission issues can be discussed and settled well in advance to the actual filling. This meeting allows the regulatory authority insight in to the proposed submission and permits them to bring their internal resources in accordance with. Ensure the challenges are...